김태형 교수

논문

•  TH Kim, IH Cha, EC Choi, HR Kim, HJ Kim, SH Kim, KC Keum, and CG Lee. Postoperative concurrent chemoradiotherapy versus radiotherapy alone for advanced oral cavity cancer in the era of modern radiation techniques. Frontiers in Oncology. 2021. March
  
   TH Kim, S Park, CH Rim, C Choi and J Seong. Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 2021. February
  
   K Kim, TH Kim, TH Kim and J Seong. Efficacy of Local Therapy for Oligometastatic Hepatocellular Carcinoma: A Propensity Score Matched Analysis. Journal of Hepatocellular carcinoma. 2021. February
  
   J Lee, TH Kim, YS kim, M Kim, JW Park, SH Kim, HJ Kim and CG Lee. Intensity-modulated radiotherapy-based reirradiation for head and neck cancer: A multi-institutional study by Korean radiation oncology group (KROG 1707). Cancer Research and Treatment. 2020. June
  
   DS Lee, CG Lee, KC Keum, SY Chung, T Kim, HG Wu, JH Kim, MW Sung, SH Ahn, KH Cho, KM Kang, YT Oh, JH Kim and MK Kang. Treatment outcomes of patients with salivary duct carcinoma undergoing surgery and postoperative radiotherapy. Acta Oncologica. 2020. Feb 21
  
   Kim TH, Lee IJ, Kim JH, Lee CG, Lee YC, Kim JW. High-dose versus standard-dose radiation therapy for cervical esophageal cancer: Retrospective single-institution study. Head Neck. 2019 Jan; 41(1):146-153.
  
   Park JW, Choi SH, Yoon HI, Lee J, Kim TH, Kim JW, and Lee IJ. Treatment outcomes of radiotherapy for anaplastic thyroid cancer. Radiat Oncol J. 2018 Jun; 36(2):103-113.
  
   Kim JW, Kim TH, KIM JH, and Lee IJ. Predictors of post-treatment stenosis in cervical esophageal cancer undergoing high-dose radiotherapy. World J Gastroenterol. 2018 Feb; 24(7):862-869.
  
   Cho Y, Kim TH, and Seong J. Improved oncologic outcome with chemoradiotherapy followed by surgery in unresectable intrahepatic cholangiocarcinoma. Strahlenther Onkol. 2017 Aug; 193(8):620-629.
  
   Lee J, Kim TH, Kim GE, Keum KC, and Kim YB. Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer. J Gynecol Oncol. 2016 Sep; 27(5):e52.
  
   Yoon HI, Koom WS, Kim TH, Ahn JB, Jung M, Kim TI, Kim H, Shin SJ, Kim NK. Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable
  Prognostic Factors. PLoS One. 2016 Aug; 11(8):e0161475
  
   Kim T, Cha HJ, Kim JW, Seong J, and Lee IJ. High dose and compartmental target volume may improve patient outcome after radiotherapy for pelvic bone metastases from hepatocellular carcinoma. Oncotarget. 2016 Aug; 7(33):53921-53929.
  
   Kim TH, Kim JS, Suh YG, Cho J, Yang WI, and Suh CO. The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma. Yonsei Med J. 2016 Jul; 57(4):846-54.
  
   Kim TH, Kim MS, Choi SH, Suh YG, Koh YW, Kim SH, Choi EC, and Keum KC. Postoperative radiotherapy in salivary ductal carcinoma: a single institution experience. Radiot Oncol J 2014; 32(3):125-131.